Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Summary of Q&AFiscal year ending March 202613 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Operating profit marginImproved due to the revenue growth in the analytical instruments and semiconductor businesses and the product mix. Specific margin: Not disclosed
Full-year earnings forecastFor the fiscal year ending March 2027, the segment plans call for higher revenue and lower profit in the analytical instruments business, and higher revenue and higher profit in the semiconductor business. Forecast figures by line item: Not disclosed
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Results for the fiscal year ending March 2026 exceeded the initial forecastKey points of the Q&AKey questions raised by investors at the briefing and the company's answers
Factors behind the upside in consolidated results, sustainability of semiconductor demand, sustainability of PFAS demand, the effects of capital investment at the 3 sites, progress on construction of the Vietnam plant, margin improvement from in-house consumables, reasons for maintaining the medium-term plan unchanged, and the earnings and dividend plans for the fiscal year ending March 2027Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
The semiconductor business benefited from a substantial order backlog, high plant utilization and a recovery in the order environment in the second half. The analytical instruments business benefited from expanding demand for PFAS analysis and margin improvement due to the product mix
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Semiconductor market conditions, customer inventory levels, semiconductor manufacturing equipment utilization rates at device manufacturers, and geopolitical risks, among other factors. Numerical assumptions: Not disclosedNew initiatives
Capital investment totaling approximately ¥7 billion in the fiscal year ending March 2027; expansion of production buildings in Kitakata, Fukushima Prefecture, and Yamagata, Yamagata Prefecture; construction of a new plant in Ninh Binh Province, Vietnam; stable supply of in-house solid-phase extraction cartridges; and expanded sales of the new Inertsil Hybrid-C18 productKey KPIsA metric the company considers important as a management benchmark.
Semiconductor business: Actual revenue of approximately ¥24 billion for the fiscal year ending March 2026; production capacity approximately 1.3 times higher when all 3 sites are fully operational; approximately 1.5 times higher production capacity at the Kitakata production building; approximately 2 times higher flame-processing capacity at the Yamagata production building; annual sales of at least ¥3 billion when the new Vietnam plant is fully operationalSegment results
Analytical instruments business: Revenue and operating profit continued to run above the figures in the medium-term management plan. Semiconductor business: It was difficult to maintain an operating margin above 20% in the fiscal year ending March 2026. Specific amounts: Not disclosedMedium-term management plan targets
As of the end of the fiscal year ending March 2026, revenue and operating profit in the analytical instruments business continued to run above the figures in the medium-term management plan. In the semiconductor business, maintaining an operating margin above 20% is difficult. Other target figures and target years: Not disclosedFinancial targets
Reference was made to an operating margin above 20% in the semiconductor business. ROE, ROIC, D/E ratio and equity ratio: Not disclosedOrders received and order backlog
The company referred to its substantial order backlog and a firm order environment. Amount: Not disclosedNumber of stores and locations
The company explained capital investment and the construction of new production facilities at 3 sites: Kitakata, Fukushima Prefecture; Yamagata, Yamagata Prefecture; and Ninh Binh Province, Vietnam. Number of locations at fiscal year-end and openings/closures: Not disclosedNumber of employees
Local recruitment and employee training are being carried out. Headcount and hiring plans: Not disclosedCapital expenditures
¥70 hundred million
| Item | Details |
|---|---|
| Document type | Summary of Q&A |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Operating profit margin | Improved due to the revenue growth in the analytical instruments and semiconductor businesses and the product mix. Specific margin: Not disclosed |
| Full-year earnings forecast | For the fiscal year ending March 2027, the segment plans call for higher revenue and lower profit in the analytical instruments business, and higher revenue and higher profit in the semiconductor business. Forecast figures by line item: Not disclosed |
| Self-assessment against the plan | Results for the fiscal year ending March 2026 exceeded the initial forecast |
| Segment results | Analytical instruments business: Revenue and operating profit continued to run above the figures in the medium-term management plan. Semiconductor business: It was difficult to maintain an operating margin above 20% in the fiscal year ending March 2026. Specific amounts: Not disclosed |
| Breakdown of Factors Affecting the Change | The semiconductor business benefited from a substantial order backlog, high plant utilization and a recovery in the order environment in the second half. The analytical instruments business benefited from expanding demand for PFAS analysis and margin improvement due to the product mix |
| Key KPIs | Semiconductor business: Actual revenue of approximately ¥24 billion for the fiscal year ending March 2026; production capacity approximately 1.3 times higher when all 3 sites are fully operational; approximately 1.5 times higher production capacity at the Kitakata production building; approximately 2 times higher flame-processing capacity at the Yamagata production building; annual sales of at least ¥3 billion when the new Vietnam plant is fully operational |
| Number of stores and locations | The company explained capital investment and the construction of new production facilities at 3 sites: Kitakata, Fukushima Prefecture; Yamagata, Yamagata Prefecture; and Ninh Binh Province, Vietnam. Number of locations at fiscal year-end and openings/closures: Not disclosed |
| Number of employees | Local recruitment and employee training are being carried out. Headcount and hiring plans: Not disclosed |
| Assumptions Underlying the Business Outlook | Semiconductor market conditions, customer inventory levels, semiconductor manufacturing equipment utilization rates at device manufacturers, and geopolitical risks, among other factors. Numerical assumptions: Not disclosed |
| Medium-term management plan targets | As of the end of the fiscal year ending March 2026, revenue and operating profit in the analytical instruments business continued to run above the figures in the medium-term management plan. In the semiconductor business, maintaining an operating margin above 20% is difficult. Other target figures and target years: Not disclosed |
| Financial targets | Reference was made to an operating margin above 20% in the semiconductor business. ROE, ROIC, D/E ratio and equity ratio: Not disclosed |
| Capital expenditures | ¥70 hundred million |
| Orders received and order backlog | The company referred to its substantial order backlog and a firm order environment. Amount: Not disclosed |
| Key points of the Q&A | Factors behind the upside in consolidated results, sustainability of semiconductor demand, sustainability of PFAS demand, the effects of capital investment at the 3 sites, progress on construction of the Vietnam plant, margin improvement from in-house consumables, reasons for maintaining the medium-term plan unchanged, and the earnings and dividend plans for the fiscal year ending March 2027 |
| New initiatives | Capital investment totaling approximately ¥7 billion in the fiscal year ending March 2027; expansion of production buildings in Kitakata, Fukushima Prefecture, and Yamagata, Yamagata Prefecture; construction of a new plant in Ninh Binh Province, Vietnam; stable supply of in-house solid-phase extraction cartridges; and expanded sales of the new Inertsil Hybrid-C18 product |
Items this document does not state (14)
Net SalesOperating profitOrdinary incomeNet incomeGross Profit MarginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastUnit price and quantity metricsRisk amount incorporated into the outlookAnnual DividendPayout ratioAcquisition of treasury sharesMarket Size / Share
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the analytical instruments business, sales of mass spectrometers and solid-phase extraction systems remained firm as demand for PFAS analysis expanded. In the semiconductor business, high plant utilization supported by a substantial order backlog and a recovery in the order environment in the second half contributed to results. Operating profit benefited from the revenue growth in both businesses and margin improvement due to the product mix.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.